Gubra A/S
Gubra A/S, a biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally. The company operates through three segments: Pre-Clinical Contract Research (CRO), Discovery & Partnerships, and Gubra Green. It offers pre-clinical contract research and development services within metab… Read more
Gubra A/S (GUBRA) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 1.899x
Based on the latest financial reports, Gubra A/S (GUBRA) has a cash flow conversion efficiency ratio of 1.899x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr2.31 Billion) by net assets (Dkr1.22 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Gubra A/S - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how Gubra A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Gubra A/S Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Gubra A/S ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NovaBridge Biosciences
NASDAQ:NBP
|
0.007x |
|
Lotte Chilsung Beverage
KO:005300
|
0.093x |
|
EUREKA FORBES LTD
NSE:EUREKAFORB
|
N/A |
|
Weltrend Semiconductor Inc
TW:2436
|
-0.037x |
|
Beijing Quanshi World Online Net
SHE:002995
|
-0.109x |
|
Jiangsu Allfavor Intelligent Circuits Technology CO.Ltd
SHE:300964
|
0.006x |
|
Poly Property Group Co. Limited
PINK:PHKIF
|
-0.049x |
|
Virgin Australia Holdings Ltd
AU:VGN
|
-0.244x |
Annual Cash Flow Conversion Efficiency for Gubra A/S (2020–2024)
The table below shows the annual cash flow conversion efficiency of Gubra A/S from 2020 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Dkr450.57 Million | Dkr5.02 Million | 0.011x | +110.81% |
| 2023-12-31 | Dkr479.66 Million | Dkr-49.42 Million | -0.103x | -145.80% |
| 2022-12-31 | Dkr108.21 Million | Dkr24.34 Million | 0.225x | -61.51% |
| 2021-12-31 | Dkr151.46 Million | Dkr88.51 Million | 0.584x | +41.74% |
| 2020-12-31 | Dkr80.01 Million | Dkr32.99 Million | 0.412x | -- |